Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)
Sanara MedTech (SMTI) reported Current Deferred Revenue of $10474.0 for Q4 2018, down 24.76% on a YoY basis from $13920.0 in Q4 2017, and down 13.73% quarter-over-quarter from $12141.0 in Q3 2018.
Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018) Analysis & Trends
Sanara MedTech has reported Current Deferred Revenue for 2 years, with the latest figure at $10474.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue fell 24.76% year-over-year to $10474.0; the trailing twelve-month figure through Dec 2018 stood at $10474.0 (down 24.76% YoY), and the FY2018 full-year result was $10474.0, down 24.76% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $10474.0, down from $12141.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $13920.0 in Q4 2017, with the low at $10474.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Sanara MedTech | 196.68 Mn | 183.08 Mn | 25.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 10,474.00 |
| Sep 30, 2018 | 12,141.00 |
| Jun 30, 2018 | 12,913.00 |
| Mar 31, 2018 | 13,703.00 |
| Dec 31, 2017 | 13,920.00 |